Management of immune thrombocytopenia: 2022 update of Korean experts recommendations

Young Hoon Park^1#, Dae-Young Kim^2#, Seongkoo Kim³, Young Bae Choi⁴, Dong-Yeop Shin⁵, Jin Seok Kim⁶, Won Sik Lee⁷, Yeung-Chul Mun¹, Jun Ho Jang⁸, Jong Wook Lee⁹, Hoon Kook¹⁰, on behalf of Korean Aplastic Anemia Working Party

¹Division of Hematology-Oncology, Department of Internal Medicine, Ewha Womans University Mokdong Hospital, ²Department of Internal Medicine, Uijeongbu Eulji Medical Center, Eulji Univerisity, ³Department of Pediatrics, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, ⁴Department of Pediatrics, Ajou University School of Medicine, Ajou Univeristy Hospital, Suwon, ⁵Department of Internal Medicine, Seoul National University Hospital, ⁶Division of Hematology, Department of Internal Medicine, Yonsei University College of Medicine, Severance Hospital, Seoul, ⁷Department of Internal Medicine, Inje University Busan Paik Hospital, Busan, ⁸Department of Hematology-Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, ⁹Department of Hematology, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, ¹⁰Department of Pediatrics, Chonnam National University Hwasun Hospital, Hwasun, Korea